- Home
- TREE vs AURA Comparison
TREE vs AURA Comparison
Compare TREE & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- AURA
- Stock Information
- Founded
- TREE 1996
- AURA 2007
- Country
- TREE United States
- AURA United States
- Employees
- TREE N/A
- AURA N/A
- Industry
- TREE Finance: Consumer Services
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- TREE Finance
- AURA Health Care
- Exchange
- TREE Nasdaq
- AURA Nasdaq
- Market Cap
- TREE 482.0M
- AURA 396.8M
- IPO Year
- TREE N/A
- AURA 2021
- Fundamental
- Price
- TREE $38.99
- AURA $6.56
- Analyst Decision
- TREE Buy
- AURA Strong Buy
- Analyst Count
- TREE 8
- AURA 6
- Target Price
- TREE $64.13
- AURA $22.33
- AVG Volume (30 Days)
- TREE 240.1K
- AURA 239.4K
- Earning Date
- TREE 07-24-2025
- AURA 08-07-2025
- Dividend Yield
- TREE N/A
- AURA N/A
- EPS Growth
- TREE N/A
- AURA N/A
- EPS
- TREE N/A
- AURA N/A
- Revenue
- TREE $972,179,000.00
- AURA N/A
- Revenue This Year
- TREE $11.20
- AURA N/A
- Revenue Next Year
- TREE $7.39
- AURA N/A
- P/E Ratio
- TREE N/A
- AURA N/A
- Revenue Growth
- TREE 51.96
- AURA N/A
- 52 Week Low
- TREE $33.50
- AURA $4.35
- 52 Week High
- TREE $62.49
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- TREE 59.21
- AURA 57.25
- Support Level
- TREE $36.38
- AURA $6.06
- Resistance Level
- TREE $36.95
- AURA $6.68
- Average True Range (ATR)
- TREE 1.33
- AURA 0.34
- MACD
- TREE 0.64
- AURA -0.01
- Stochastic Oscillator
- TREE 91.48
- AURA 80.00
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.